These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8323291)
1. Aromatic hydrocarbon binding to cytochrome P450 and other enzyme binding sites: are hydrophobic compounds drawn into the active site or pushed from the aqueous phase? Backes WL; Cawley G; Eyer CS; Means M; Causey KM; Canady WJ Arch Biochem Biophys; 1993 Jul; 304(1):27-37. PubMed ID: 8323291 [TBL] [Abstract][Full Text] [Related]
2. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808 [TBL] [Abstract][Full Text] [Related]
3. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9. Mancy A; Dijols S; Poli S; Guengerich P; Mansuy D Biochemistry; 1996 Dec; 35(50):16205-12. PubMed ID: 8973193 [TBL] [Abstract][Full Text] [Related]
4. Time course for the modulation of hepatic cytochrome P450 after administration of ethylbenzene and its correlation with toluene metabolism. Yuan W; Sequeira DJ; Cawley GF; Eyer CS; Backes WL Arch Biochem Biophys; 1997 Mar; 339(1):55-63. PubMed ID: 9056233 [TBL] [Abstract][Full Text] [Related]
5. Hydration energy landscape of the active site cavity in cytochrome P450cam. Helms V; Wade RC Proteins; 1998 Aug; 32(3):381-96. PubMed ID: 9715913 [TBL] [Abstract][Full Text] [Related]
6. Relationship between hydrocarbon structure and induction of P450: effects on protein levels and enzyme activities. Backes WL; Sequeira DJ; Cawley GF; Eyer CS Xenobiotica; 1993 Dec; 23(12):1353-66. PubMed ID: 8135039 [TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of benzoate-para-hydroxylase, a cytochrome P450 (CYP53A1), from Aspergillus niger. Faber BW; van Gorcom RF; Duine JA Arch Biochem Biophys; 2001 Oct; 394(2):245-54. PubMed ID: 11594739 [TBL] [Abstract][Full Text] [Related]
8. Compound lipophilicity for substrate binding to human P450s in drug metabolism. Lewis DF; Jacobs MN; Dickins M Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161 [TBL] [Abstract][Full Text] [Related]
9. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase. Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704 [TBL] [Abstract][Full Text] [Related]
10. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides. Jousserandot A; Boucher JL; Henry Y; Niklaus B; Clement B; Mansuy D Biochemistry; 1998 Dec; 37(49):17179-91. PubMed ID: 9860831 [TBL] [Abstract][Full Text] [Related]
11. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase. Roitel O; Scrutton NS; Munro AW Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506 [TBL] [Abstract][Full Text] [Related]
12. The function of tyrosine 74 of cytochrome b5. Vergères G; Chen DY; Wu FF; Waskell L Arch Biochem Biophys; 1993 Sep; 305(2):231-41. PubMed ID: 8373159 [TBL] [Abstract][Full Text] [Related]
13. Characterization of bromosulphophthalein binding to human glutathione S-transferase A1-1: thermodynamics and inhibition kinetics. Kolobe D; Sayed Y; Dirr HW Biochem J; 2004 Sep; 382(Pt 2):703-9. PubMed ID: 15147239 [TBL] [Abstract][Full Text] [Related]
14. Activation of microsomal glutathione S-transferase and inhibition of cytochrome P450 1A1 activity as a model system for detecting protein alkylation by thiourea-containing compounds in rat liver microsomes. Onderwater RC; Commandeur JN; Menge WM; Vermeulen NP Chem Res Toxicol; 1999 May; 12(5):396-402. PubMed ID: 10328749 [TBL] [Abstract][Full Text] [Related]
15. The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity. Nelson SD; Trager WF Drug Metab Dispos; 2003 Dec; 31(12):1481-98. PubMed ID: 14625345 [TBL] [Abstract][Full Text] [Related]
16. In vitro screening of carcinogenesis inhibitors acting by inhibition of microsomal polycyclic aromatic hydrocarbon activation. Safirman C; Stoica G; Lupu F; Voiculetz N; Niculescu-Duvaz I Neoplasma; 1987; 34(3):261-8. PubMed ID: 3614462 [TBL] [Abstract][Full Text] [Related]
17. Water regulation of actinomycin-D binding to DNA: the interplay among drug affinity, DNA long-range conformation, and hydration. Ruggiero Neto J; Colombo MF Biopolymers; 2000 Jan; 53(1):46-59. PubMed ID: 10644950 [TBL] [Abstract][Full Text] [Related]
18. Water accessibility to the binding cleft as a major switching factor from entropy-driven to enthalpy-driven binding of an alkyl group by synthetic receptors. Matsumoto S; Iwamoto H; Mizutani T Chem Asian J; 2010 May; 5(5):1163-70. PubMed ID: 20379991 [TBL] [Abstract][Full Text] [Related]
19. Improved binding of cytochrome P450cam substrate analogues designed to fill extra space in the substrate binding pocket. Helms V; Deprez E; Gill E; Barret C; Hui Bon Hoa G; Wade RC Biochemistry; 1996 Feb; 35(5):1485-99. PubMed ID: 8634279 [TBL] [Abstract][Full Text] [Related]
20. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site. Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]